BlackRock Institutional Trust Company, N.A. - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 66 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2016$1,396,000
+20.8%
303,516
+11.3%
0.00%
Q3 2016$1,156,000
+84.1%
272,705
+4.2%
0.00%
Q2 2016$628,000
-32.2%
261,678
+32.8%
0.00%
Q1 2016$926,000
+18.9%
197,074
-0.5%
0.00%
Q4 2015$779,000
+10.3%
198,103
+8.6%
0.00%
Q3 2015$706,000
+108.9%
182,377
+148.0%
0.00%
Q2 2015$338,000
+412.1%
73,531
+648.1%
0.00%
Q1 2015$66,0009,8290.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,699,848$15,687,0002.68%
Northeast Financial Consultants Inc 732,265$3,105,0001.31%
WEDBUSH SECURITIES INC 15,000$64,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$628,0000.01%
THRIVENT FINANCIAL FOR LUTHERANS 413,278$1,752,0000.01%
Virtu KCG Holdings LLC 72,989$309,0000.01%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,555$151,0000.00%
WILLIAMS JONES & ASSOCIATES LLC 15,100$64,0000.00%
BlackRock Fund Advisors 612,231$2,596,0000.00%
Spot Trading L.L.C 15,000$64,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders